Xin-lan Luo

PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer

Li‐Xu Yan, Yan‐Hui Liu, Jianwen Xiang et al. · International Journal of Oncology · 2015 · 131 citations · Full text

Medicine, Molecular Biology, Oncology +17

MYC Expression in Concert with BCL2 and BCL6 Expression Predicts Outcome in Chinese Patients with Diffuse Large B-Cell Lymphoma, Not Otherwise Specified

Li‐Xu Yan, Yan‐Hui Liu, Donglan Luo et al. · PLoS ONE · 2014 · 80 citations · Full text

Medicine, Hematology, Oncology +17

Diffuse large B cell lymphoma associated with chronic inflammation arising within atrial myxoma: aggressive histological features but indolent clinical behaviour

Jinhai Yan, Donglan Luo, Fen Zhang et al. · Histopathology · 2017 · 30 citations

Medicine, Hematology, Oncology +10

Fbw7 regulates apoptosis in activated B-cell like diffuse large B-cell lymphoma by targeting Stat3 for ubiquitylation and degradation

Su Yao, Fangping Xu, Yu Chen et al. · Journal of Experimental & Clinical Cancer Research · 2017 · 29 citations · Full text

Life Sciences, Cancer Biology, Oncology +16

Justification of the Change From 10% to 30% for the Immunohistochemical HER2 Scoring Criterion in Breast Cancer

Yan‐Hui Liu, Fangping Xu, Jianyu Rao et al. · American Journal of Clinical Pathology · 2009 · 21 citations · Full text

Medicine, Cancer Biology, Oncology +16